Literature DB >> 19381504

Serum homocysteine in Indian adolescents.

Pratima Anand1, Shally Awasthi, Abbas Mahdi, Manoj Tiwari, G G Agarwal.   

Abstract

OBJECTIVE: To assess serum homocysteine levels and its association with conventional risk factors for cardiovascular disease (CVD) in Indian adolescents.
METHODS: This was a cross-sectional study conducted in tertiary care hospital in northern India in apparently healthy adolescents aged 10-19 yr. A pre-designed questionnaire was used to assess conventional risk factors. Serum homocysteine levels of > or = 12 micromol/L, serum triglycerides > or = 150 mg% and serum cholesterol > or = 200 mg% were taken as hyperhomocysteinemia, hypertriglyceridemia and hypercholesterolemia, respectively. Serum high-density lipoprotein (HDL) > or = 40 mg% was considered protective for CVD.
RESULTS: In 103 subjects, 36.87 % females, mean serum homocysteine level was 11.649 +/-0.416 micromol/L. Hyperhomocysteinemia was present in 46 (44.6%, 95% CI: 34.965-54.75) subjects. Dietary deficiency of vitamin B12 and folic acid, body mass index (BMI) > 84(th) percentile and altered lipid profile were associated with hyperhomocysteinemia on univariate analysis. After multivariate adjustment for BMI and vegetarian diet, low serum HDL (OR: 23.81, 95% CI: 2.86-200; p = 0.003) and serum hypertriglyceridemia (OR: 4.17, 95% CI: 1.51-13.51; p = 0.022) had independent association with hyperhomocysteinemia.
CONCLUSION: Since we have also found an association between hyperhomocysteinemia and low serum HDL levels and hypertriglyceridemia, which are conventional risk factors for CVD, interventional strategies are urgently needed among adolescents for prevention of CVD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381504     DOI: 10.1007/s12098-009-0116-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.

Authors:  Sanjay Kaul; Andrew A Zadeh; Prediman K Shah
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

3.  Dietary recommendations for children and adolescents: a guide for practitioners.

Authors:  Samuel S Gidding; Barbara A Dennison; Leann L Birch; Stephen R Daniels; Matthew W Gillman; Matthew W Gilman; Alice H Lichtenstein; Karyl Thomas Rattay; Julia Steinberger; Nicolas Stettler; Linda Van Horn
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

4.  Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents.

Authors:  Martina Huemer; Kurt Vonblon; Manuela Födinger; Ruth Krumpholz; Michael Hubmann; Hanno Ulmer; Burkhard Simma
Journal:  Pediatr Res       Date:  2006-10-25       Impact factor: 3.756

5.  Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.

Authors:  S K Osganian; M J Stampfer; D Spiegelman; E Rimm; J A Cutler; H A Feldman; D H Montgomery; L S Webber; L A Lytle; L Bausserman; P R Nader
Journal:  JAMA       Date:  1999-04-07       Impact factor: 56.272

6.  Plasma homocysteine predicts progression of atherosclerosis.

Authors:  M Leila Rasouli; Khurram Nasir; Roger S Blumenthal; Robert Park; Douglas C Aziz; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2005-07       Impact factor: 5.162

7.  New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents.

Authors:  Barbara Glowinska; Miroslawa Urban; Alicja Koput; Marzena Galar
Journal:  Atherosclerosis       Date:  2003-04       Impact factor: 5.162

8.  Plasma homocysteine concentration and coronary artery disease in Asian Indians.

Authors:  C Snehalatha; A Ramachandran; K Satyavani; S Sivasankari; I Sathyamurthy; V Viswanathan
Journal:  J Assoc Physicians India       Date:  2002-10

9.  Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.

Authors:  K G Nair; S R Nair; T F Ashavaid; J J Dalal; F F Eghlim
Journal:  J Assoc Physicians India       Date:  2002-05

10.  Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage?

Authors:  G Frauscher; E Karnaukhova; A Muehl; H Hoeger; B Lubec
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  4 in total

1.  Prevalence of Vitamin B12 and Folate Deficiency in School Children Residing at High Altitude Regions in India.

Authors:  Aakriti Gupta; Umesh Kapil; Lakshmy Ramakrishnan; Ravindra Mohan Pandey; Chander Prakash Yadav
Journal:  Indian J Pediatr       Date:  2017-01-21       Impact factor: 1.967

Review 2.  Undernutrition and Overnutrition Burden for Diseases in Developing Countries: The Role of Oxidative Stress Biomarkers to Assess Disease Risk and Interventional Strategies.

Authors:  Francesca Mastorci; Cristina Vassalle; Kyriazoula Chatzianagnostou; Claudio Marabotti; Khawer Siddiqui; Ahmed Ould Eba; Soueid Ahmed Sidi Mhamed; Arun Bandopadhyay; Marco Stefano Nazzaro; Mirko Passera; Alessandro Pingitore
Journal:  Antioxidants (Basel)       Date:  2017-06-08

3.  Prevalence of hyperhomocysteinemia in healthy Indian doctors.

Authors:  Sandesh P Kamdi; Prashant Palkar
Journal:  Bioinformation       Date:  2013-02-21

4.  Metabolic distress in lipid & one carbon metabolic pathway through low vitamin B-12: a population based study from North India.

Authors:  Kallur Nava Saraswathy; Shipra Joshi; Suniti Yadav; Priyanka Rani Garg
Journal:  Lipids Health Dis       Date:  2018-04-25       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.